C
Overview
Private investment firm near Chicago focused on strategic, long-term assets. The team applies decades of experience as operators and investors in healthcare, finance, and real estate to identify and grow value in private markets. It does not act as an investment adviser and does not accept outside capital, using its own resources to acquire and optimize assets. The goal is to build durable value in healthcare, finance, and real estate through patient, value-driven investments.
Work here?Claim your company
Simplify's take
What believers are saying
- PDW raised $110 million in November 2025, validating Cedar Pine's defense thesis.
- Wasabi's $250 million September 2022 financing expanded Cedar Pine's cloud infrastructure exposure.
- APC's January 2024 recapitalization shows Cedar Pine can source healthcare growth platforms.
What critics are saying
- Public visibility remains thin; Cedar Pine disclosed only eight investments by November 2026.
- PDW concentration exposes returns if defense procurement slows or contract timing slips in 2027.
- Family-office capital creates existential risk if one large portfolio company stalls or misfires.
What makes Cedar Pine unique
- Northbrook-based Cedar Pine writes direct checks into healthcare, defense, and real assets.
- Its 2026 hiring emphasizes control deals, de novo financings, and follow-on capital.
- The firm uses operator-investor experience, not outside LP capital, to move quickly.
Help us improve and share your feedback! Did you find this helpful?